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Objective: To evaluate the role of deep vein thrombosis as a cause of leg ulcers.
Patients and methods: A population-based, case-control study was conducted in Central and North Auckland, New
Zealand. Cases comprised 241 people aged 40 to 99 years and on the electoral roll, with current leg ulcers (all types).
Cases were identified by means of notification from health professionals and by self-referral. Controls were 224 people in
the same age group, without leg ulcers, who were selected from the electoral roll by using a stratified random sampling
process.
Main outcome measures: The occurrence of leg ulceration as a consequence of exposure to deep vein thrombosis or being
at high risk of deep vein thrombosis (that is, people with a family history of deep vein thrombosis, and/or a history of leg
fracture and/or hip, leg, or foot surgery).
Results: After adjustment for age, sex, and other potential confounding factors, people who had a diagnosed thrombo-
embolism were at almost three times higher risk of having a leg ulcer (odds ratio, 2.92; 95% confidence interval (CI), 1.47
to 6.08). In addition, people who had been at high risk of a venous thrombosis but were not diagnosed with this
condition (eg, people with a history of major leg surgery) were also at increased risk of ulceration (odds ratio, 2.25; 95%
CI, 1.49-3.42). Overall, 56% (95% CI, 33% - 71%) of leg ulcers were attributed to being at high risk of deep vein
thrombosis.
Conclusions: Deep vein thrombosis and factors that place people at high risk of deep vein thrombosis are an important
cause of leg ulcers in older people. This finding strengthens the rationale for the routine and long-term use of
thromboprophylaxis, particularly in high-risk patients. (J Vasc Surg 2003;38:1331-5.)
Little attention has been given to long-term complica-
tions associated with deep vein thrombosis, such as leg
ulceration. Research suggests that chronic venous insuffi-
ciency, including leg ulceration, can occur a number of
years after a venous thromboembolism.1-4 For example, in
a 13-year follow-up study of 223 patients with symptomatic
deep vein thrombosis diagnosed by phlebography, 39%
developed chronic venous insufficiency and 10% developed
leg ulcers.2 However, the exact role of deep vein thrombo-
sis in the development of leg ulcers has not been quantified
reliably. Three case-control studies (with 109 to 317 pa-
tients) have reported an increased risk of leg ulcer associ-
ated with a prior history of deep vein thrombosis.5-7 How-
ever, these studies had a number of methodologic
limitations (ie, variable case definitions, different age
groups, and different selection processes for cases and
controls), and two of the three did not present results
adjusted for potential confounders.5,6 There are no pub-
lished data on the risk of undiagnosed or asymptomatic
deep vein thrombosis and leg ulcer development, or the risk
associated with being at high risk of venous thrombosis
(such as having a history of major leg surgery). Given the
limitations of existing studies on risk factors for leg ulcers,
we conducted a large population-based, case-control study
on risk factors for leg ulceration. In this article, we report
the relation between deep vein thrombosis and leg ulcers.
METHODS
Subjects. The study aimed to identify all individuals
who had or developed a leg ulcer in the North Auckland
and Central Auckland health districts of New Zealand over
a 12-month period. A leg ulcer was defined as any break in
the skin on the leg (below the knee) or on the foot that had
been present for more than 6 weeks. Cases were identified
through notifications from health professionals and by self-
notification. Relevant health professionals were contacted
and asked to notify the study center of patients they en-
countered who had a current leg ulcer or who developed a
leg ulcer during the study period. The self-referral pathway
consisted of advertising a toll-free telephone number by
means of newspaper advertisements and poster displays
throughout the community. Full details of the case identi-
fication procedures are detailed in a previous publication.8
All ulcer types were investigated.
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Prevalent and incident patients aged between 40 and
99 years and on the electoral roll were invited to participate
in the case-control study. An incident patient was a person
who developed a leg ulcer during the study period. A
prevalent patient was a person with a current ulcer that
developed before the study period. Controls were individ-
uals aged between 40 and 99 years, without leg ulcers and
resident within the study region. Controls were selected
from the electoral roll by using a stratified random sampling
process, whereby equal numbers of controls were selected
from each 10-year age group. Cases and controls were not
matched.9 Controls had the potential to be included as
cases if they later developed ulcers, although none did.
Ethical approval for this study was obtained from the
Auckland Ethics Committee, and all subjects gave in-
formed consent to participate.
Data collection. Data collection was carried out in the
participant’s home, and it involved an interviewer-admin-
istered risk factor questionnaire, clinical examination,
blood tests, health-related quality of life questionnaire,
Mini-Mental State Examination, and food-frequency ques-
tionnaire. A bidirectional MD2 multi-Doppler with an
8-MHz probe was used to assess arterial function10 and
calculate an ankle:brachial pressure index.
Participants were asked if they had ever been diagnosed
with deep vein thrombosis. In addition, as many cases of
deep vein thrombosis are undiagnosed and/or symptom-
free, participants were asked if they had had one or more
situations associated with high risk of venous thrombosis.
This high-risk group included people with a family history
of deep vein thrombosis and/or a history of leg fracture
and/or hip, leg, or foot surgery. These exposures were not
confirmed against hospital or clinic records.
Socioeconomic status was classified according to the
International Socio-economic Index of Occupational Sta-
tus,11 which scores occupation from 0 (low social class) to
100 (high social class). For all retired or currently employed
male participants, main occupation in lifetime was used.
Given the older age of women in this study, their spouse’s
or partner’s main occupation was used as an indicator of
their social class. If a woman had never married, their
father’s main occupation was used for coding.
Statistical analyses. Odds ratios (OR) and 95% confi-
dence intervals (CI) were calculated, with unadjusted anal-
yses undertaken by using the Mantel–Haenzel 2 test.
Potential confounding factors were adjusted for with un-
conditional multiple logistic regression analysis, by using
the minimal credible model.9,12 The change-in-estimate
method was used for variable selection,9,12,13 although age
and gender were forced into each model, as previous data
indicate that these factors are important in the development
of leg ulcers.8 The following confounding factors were
adjusted for: age, gender, leg fracture, cardiovascular dis-
ease, cancer, hip, leg or foot surgery, body mass index,
socioeconomic status, and current smoking. Population-
attributable risk percent was calculated with adjusted rela-
tive risk estimates by using the following formula: ([OR 
1]/OR)  proportion of exposed cases.9,14
Prespecified subgroup analyses were conducted accord-
ing to ulcer type (venous, nonvenous, or diabetic leg ulcer
cases), ulcer event (first-ever or recurrent leg ulcer cases),
and case type (incident or prevalent cases). The venous
subgroup included people with an ankle-brachial index of
0.6, and the nonvenous subgroup included people with
an ankle-brachial index of0.6. People with diabetes were
analyzed separately, as diabetes can result in falsely high
ankle-brachial index measurements due to noncompress-
ible arteries. The Breslow–Day test for homogeneity of the
observed ORs was calculated for each exposure of interest
within each subgroup.15
RESULTS
Recruitment and data availability. Three hundred
and eighty cases and 394 controls met the inclusion criteria
for the study. Of these people, 128 cases and 170 controls
declined to participate, giving an overall response rate of
66% and 57%, respectively. Of the 476 people who were
eligible for the study and agreed to participate, 11 (2%) died
before they could be interviewed. Overall, 241 patients and
224 controls were interviewed, giving a participation rate of
60% for cases and 57% for controls. Information was ob-
tained from next of kin or legal guardians for 14 (3%)
people due to Mini-Mental State Examination scores sug-
gestive of mild to severe cognitive impairment. Details of
potential confounding variables are summarized in Table I.
Ankle-brachial index readings were not available from
5% of the 241 interviewed patients, leaving 230 cases
available for investigation. Forty-two (18%) of these pa-
tients were analyzed separately as they had a history of
diabetes. Almost three-quarters (73%) of patients had an
ankle-brachial index that indicated venous insufficiency,
and 9% had an index suggestive of nonvenous etiology. Of
the 205 patients with a leg ulcer at the time of interview, 83
(40%) were experiencing their first-ever leg ulcer and 121
(59%) had recurrent leg ulcers. One hundred and eleven
(46%) people were considered prevalent cases, and 104
(43%) were incident cases. Twenty-six cases (11%) were
unable to be coded as incident or prevalent due to missing
information, and they were therefore excluded from sub-
group analyses.
The role of deep vein thrombosis as a cause of leg
ulcers. Adjusted analyses indicated that people with a his-
tory of deep vein thrombosis were almost three times more
likely to have a leg ulcer than were people without a history
of venous thrombosis (OR  2.92, 95% CI  1.47-6.08)
[Table II, Fig 1]. Furthermore, the risk of developing a leg
ulcer was more than twice as likely in people who had been
at high risk of venous thrombosis (OR  2.25, 95% CI 
1.49-3.42) [Table II, Fig 2].
The population-attributable risk is the proportion by
which the occurrence of leg ulcers would be reduced if a
particular risk factor were eliminated from the population.
The population-attributable risk for being at high risk of
deep vein thrombosis was 33% (95% CI, 19% to 42%),
indicating the importance of this exposure in the study
population. The population-attributable risk percent for
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deep vein thrombosis was much lower at 11% (95% CI, 5%
to 13%).
Subgroup analyses. Subgroup analyses for diagnosed
deep vein thrombosis did not indicate significant heteroge-
neity between ulcer type (P-value for heterogeneity  .8),
ulcer event (P-value for heterogeneity  .2) or case type
(P-value for heterogeneity  .9) (Fig 1). However, the
study only had adequate power to detect large subgroup
effects. Similar findings were found for those at high risk of
venous thromboembolism (data not presented).
Stratified analysis showed no clear evidence that the
strength or direction of the association between deep vein
thrombosis and leg ulcers varied according to the presence
or absence of varicose veins. Although there was a nonsig-
nificant trend toward increased risk in people with varicose
veins and a history of deep vein thrombosis (OR, 1.35; 95%
CI, 0.62 to 2.94) and clear evidence of increased ulcer risk
in people with a history of deep vein thrombosis but no
varicose veins (OR, 4.53; 95% CI, 1.37 to 14.95), the test
for heterogeneity between these two strata was not found
to be statistically significant at the conventional 5% level
(P  .1).
DISCUSSION
This study found a threefold increase in the risk of
developing leg ulcers in those people with a history of deep
vein thrombosis. Furthermore, these findings can be ex-
tended to a broad range of people who have been at high
risk of venous thromboembolism, such as those that have
had major leg surgery. Overall, one to two thirds of leg
ulcers can be attributed to factors that place people at high
risk of deep vein thrombosis.
Strengths and weaknesses. This study is one of the
most comprehensive observational studies on leg ulcers
conducted to date. The study had a large sample size and
adjusted for potential confounding. Response rates were
modest, although typical of such an elderly population.
Although these rates may raise the possibility of selection
bias, which theoretically could result in either an overesti-
mate or underestimate of the ORs, it is difficult to see why
cases or controls would differentially participate in the
study according to their history of deep vein thrombosis.
Including self-notified cases in the study and incomplete
ascertainment of cases is also likely to have introduced some
degree of selection bias, which means that the ORs ob-
tained may be slightly overestimated or underestimated. It
is acknowledged that as a large proportion of venous
thromboembolisms are asymptomatic, any estimate of the
risk associated with this exposure is likely to be underesti-
mated, and any difference (or lack of difference) observed
with subgroup analyses may be spurious. Furthermore, the
inability to clarify the exact temporal relationship between
deep vein thrombosis and ulcer formation means that any
estimate of the risk associated with this exposure may be
underestimated. The extent of recall bias and misclassifica-
tion of exposure in cases was likely to have been similar to
that of controls, and it would have biased any observed
associations toward the null.
Comparison with other studies. The observation
that a history of deep vein thrombosis increases the risk of
leg ulcer development is consistent with results from three
other observational studies on risk factors for leg ulcers.5-7
An unadjusted OR calculated with data reported in the
study by Andersson et al5 suggests a very strong association
between venous leg ulcers and history of deep vein throm-
bosis (OR, 17.8; 95% CI, 4.3 to 73.9). Similarly, the study
published by Scott et al7 reported an extremely high ad-
justed OR (OR, 25.7; 95% CI, 7.6 to 86.5) for venous leg
ulcers for this exposure. An unadjusted OR calculated by
using data reported in the unpublished study from Nelzen
et al6 also shows a clear association between ulcer develop-
ment (all types) and history of venous thromboembolism
(OR, 6.1; 95% CI, 2.6 to 14.2). Although the direction of
the association between history of deep vein thrombosis
and leg ulcers is clear from these studies, the strength of
the association is less certain. As deep vein thrombosis is
Table I. Baseline characteristics of people with leg ulcers
compared to controls
Exposure of
interest
Number of cases
(N  241)
Number of
controls
(N  224)
n % n %
Gender
Female 142 59% 122 54%
Male 99 41% 102 46%
Age group (years)
40–49 7 3% 42 19%
50–59 17 7% 38 17%
60–69 33 14% 42 19%
70–79 84 35% 45 20%
80–89 95 39% 34 15%
90–99 5 2% 23 10%
Previous leg fracture
Yes 67 28% 41 18%
No 174 72% 183 82%
History of cardiovascular disease
Yes 95 39% 54 24%
No 142 59% 168 75%
Current or history of cancer
Yes 27 11% 14 6%
No 210 87% 204 91%
History of hip, leg or foot surgery
Yes 104 43% 58 26%
No 137 57% 166 74%
Current cigarette smoker
Yes 27 11% 23 10%
No 212 88% 199 89%
Current or history of varicose veins
Yes 140 58% 73 33%
No 92 38% 140 63%
Body mass index (kg/m2)
Obese (30) 71 29% 56 25%
Not obese (  30) 159 66% 164 73%
Occupational status index
Low status (ISEI  35) 71 29% 54 24%
Middle status (ISEI 35–66) 114 47% 97 43%
High status (ISEI  66) 52 22% 70 31%
ISEI, International Socio-economic Index of Occupational Status.
Numbers do not always tally due to missing data.
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a rare event, all four studies had wide confidence intervals
and so were unable to precisely measure the true associ-
ation. The Auckland study was the largest of the four
studies and therefore had more power to detect a rela-
tionship and greater precision to quantify the size of the
relationship.
Very little research has been undertaken on the associ-
ation between asymptomatic venous thromboembolism
and leg ulceration. The current study suggests that in
people without diagnosed deep vein thrombosis but at high
risk of such an event (and therefore possibly with asymp-
tomatic deep vein thrombosis), the risk of developing a leg
ulcer is increased. This finding is supported by a study that
found 24% of orthopedic patients with previous asymptom-
atic venous thrombosis developed chronic venous insuffi-
ciency 2 to 4 years after surgery.16
Table II. Univariate and adjusted odds ratios for risk of leg ulcers due to deep vein thrombosis
Exposure of
interest
No. (%) of cases
(N  241)
No. (%) of controls
(N  224)
Odds ratio (95% confidence interval)
Unadjusted data Adjusted data*
Diagnosed deep vein thrombosis
Yes 36 (15%) 16 (7%) 2.55 (1.37–4.74) 2.92 (1.47–6.08)
No 183 (76%) 207 (92%) 1.00 — 1.00 —
High risk of deep vein thrombosis
†
Yes 142 (59%) 91 (41%) 2.10 (1.45–3.04) 2.25 (1.49–3.42)
No 99 (41%) 133 (59%) 1.00 — 1.00 —
*Adjusted for age and sex. All other potential confounding factors investigated failed to change the point estimate by more than 10%.
†
Defined as people with a family history of deep vein thrombosis and/or a history of leg fracture and/or hip, leg, or foot surgery.
Numbers do not always tally due to missing data.
Fig 1. Odds ratio and 95% confidence intervals for deep vein
thrombosis as a risk factor for leg ulcers (subgroup analysis in-
cluded).
Fig 2. Odds ratio and 95% confidence intervals for being at high
risk of deep vein thrombosis and leg ulcer risk (with the three
components of the exposure shown).
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Results from the Auckland study do not support the
observation from univariate analysis from a case-control
study6 that deep vein thromboses are more common in
venous leg ulcer cases than nonvenous leg ulcer cases. This
finding, however, may simply reflect the inability of all three
studies to accurately classify leg ulcers by type or detect
deep vein thromboses. Alternatively, it may also reflect the
fact that many leg ulcers are of mixed etiology. No study on
risk factors for leg ulcers has investigated deep vein throm-
boses as a risk factor for first-ever versus recurrent leg ulcers
or prevalent versus incident leg ulcers. Furthermore, to our
knowledge, population-attributable risk for risk factors spe-
cific to leg ulcers have never previously been reported.
Prevention of leg ulcers. Our study shows that deep
vein thrombosis and factors that place a person at high risk
of deep vein thrombosis make a significant contribution to
the burden of leg ulcers in this population. Consequently,
these data add to the rationale for the routine and long-
term use of thromboprophylaxis, particularly in high-risk
patients. In many, the short-term costs and side-effects of
such treatment may be considerably outweighed by the
prevention of acute and long-term complications.17,18
We would like to acknowledge all study-related staff,
participating health professionals, and study participants.
All authors were involved in planning the study, obtaining
funding, interpreting the results, and writing the article. N.
Walker conducted all data analyses.
REFERENCES
1. Prandoni P, Lensing A, Cogo A, Cuppini S, Villalta S, Carta M, et al.
The long-term clinical course of acute deep vein thrombosis. Ann Intern
Med 1996;125:1-7.
2. Eichlisberger R, Frauchiger B, Widmer M, Widmer L, Jager K. Late
sequelae of deep vein thrombosis: a 13-year follow-up of 223 patients.
VASA 1994;23:234-43.
3. Heldel M, Seem E, Sandset PM, Abildgaard U. Deep vein thrombosis:
a 7-year follow-up study. J Intern Med 1993;234:71-5.
4. Monreal M, Martorell A, Callejas JM, Valls R, Llamazares JF, Lafoz E,
et al. Venographic assessment of deep vein thrombosis and risk of
developing post-thrombotic syndrome: a prospective study. J Intern
Med 1993;233:233-8.
5. Andersson E, Hansson C, Swanbeck G. Leg and foot ulcer prevalence
and investigation of the peripheral arterial and venous circulation in a
elderly population: an epidemiological survey and clinical investigation.
Acta Derm Venereol (Stockh) 1993;73:57-61.
6. Nelzen O, Bergqvist D, Lindhagen A. General health, socioeconomic
factors and lifestyle in patients with chronic lower limb ulceration: a
case-control questionnaire study [PhD dissertation]. Uppsala Univer-
sity, Uppsala, Sweden, 1997.
7. Scott TE, LaMorte WW, Gorin DR, Menzoian JO. Risk factors for
chronic venous insufficiency: a dual case-control study. J Vasc Surg
1995;22:622-8.
8. Walker N, Rodgers A, Birchall N, Norton R, MacMahon S. The
occurrence of leg ulcers in Auckland, New Zealand: results of a popu-
lation-based study. NZ Med J 2002;115:159-62.
9. Rothman K, Greenland S. Modern epidemiology. 2nd ed. Philadelphia:
Lippincott-Raven, 1998.
10. Vowden K, Goulding V, Vowden P. Hand-held Doppler assessment for
peripheral arterial disease. J Wound Care 1996;5:125-7.
11. Ganzeboom H, Treiman D. Internationally comparable measures of
occupational status for the 1988 international standard classification of
occupations. Soc Sci Res 1996;25:201-39.
12. Greenland S. Modeling and variable selection in epidemiologic analysis.
Am J Public Health 1989;79:340-9.
13. Maldonado G, Greenland S. Simulation study of confounder-selection
strategies. Am J Epidemiol 1993;138:923-36.
14. Rockhill B, Newman B, Weinberg C. Use and misuse of population
attributable fractions. Am J Public Health 1998;88:15-9.
15. Kahn H, Sempos C. Statistical methods in epidemiology. Oxford:
Oxford University Press; 1989.
16. Siragusa S, Beltrametti C, Barone M, Piovella F. Clinical course and
incidence of post-thrombophlebitic syndrome after profound asymp-
tomatic deep vein thrombosis. Results of a transverse epidemiologic
study. Minerva Cardioangiol 1997;45:57-66.
17. Sarasin F, Bounameaux H. Antithrombotic strategy after total hip
replacement: a cost effectiveness analysis comparing prolonged oral
anticoagulants with screening for deep vein thrombosis. Arch Intern
Med 1996;156:1661-8.
18. Bergqvist D, Jendteg S, Johansen L, Persson U, Odegaard K. Cost of
long-term complications of deep vein thrombosis of the lower extrem-
ities: an analysis of a defined population in Sweden. Ann Intern Med
1997;126:454-7.
Submitted Jan 9, 2003; accepted May 16, 2003.
JOURNAL OF VASCULAR SURGERY
Volume 38, Number 6 Walker et al 1335
